GRANULES PHARMS FDA Approval ANDA 213469

ANDA 213469

GRANULES PHARMS

FDA Drug Application

Application #213469

Application Sponsors

ANDA 213469GRANULES PHARMS

Marketing Status

Prescription001

Application Products

001FOR SOLUTION;ORAL500MG/PACKET0VIGABATRINVIGABATRIN

FDA Submissions

UNKNOWN; ORIG1AP2020-04-24STANDARD
LABELING; LabelingSUPPL2AP2022-10-25STANDARD
REMS; REMSSUPPL3AP2022-10-12

Submissions Property Types

ORIG1Null7
SUPPL2Null15
SUPPL3Null31

TE Codes

001PrescriptionAA

CDER Filings

GRANULES PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213469
            [companyName] => GRANULES PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"VIGABATRIN","activeIngredients":"VIGABATRIN","strength":"500MG\/PACKET","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/24\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"10\/02\/2020","submission":"SUPPL-1","supplementCategories":"REMS - MODIFIED - D-N-A","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-10-02
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.